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Endurance exercise training can promote an adaptive muscle fiber transformation and an increase of mitochondrial
biogenesis by triggering scripted changes in gene expression. However, no transcription factor has yet been identified
that can direct this process. We describe the engineering of a mouse capable of continuous running of up to twice the
distance of a wild-type littermate. This was achieved by targeted expression of an activated form of peroxisome
proliferator-activated receptor d (PPARd) in skeletal muscle, which induces a switch to form increased numbers of type I
muscle fibers. Treatment of wild-type mice with PPARd agonist elicits a similar type I fiber gene expression profile in
muscle. Moreover, these genetically generated fibers confer resistance to obesity with improved metabolic profiles,
even in the absence of exercise. These results demonstrate that complex physiologic properties such as fatigue,
endurance, and running capacity can be molecularly analyzed and manipulated.
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Introduction
Skeletal muscle ﬁbers are generally classiﬁed as type I
(oxidative/slow) or type II (glycolytic/fast) ﬁbers. They display
marked differences in respect to contraction, metabolism,
and susceptibility to fatigue. Type I ﬁbers are mitochondria-
rich and mainly use oxidative metabolism for energy
production, which provides a stable and long-lasting supply
of ATP, and thus are fatigue-resistant. Type II ﬁbers comprise
three subtypes, IIa, IIx, and IIb. Type IIb ﬁbers have the lowest
levels of mitochondrial content and oxidative enzymes, rely
on glycolytic metabolism as a major energy source, and are
susceptible to fatigue, while the oxidative and contraction
functions of type IIa and IIx lie between type I and IIb (Booth
and Thomason 1991; Berchtold et al. 2000; Olson and
Williams 2000). Adult skeletal muscle shows plasticity and
can undergo conversion between different ﬁber types in
response to exercise training or modulation of motoneuron
activity (Booth and Thomason 1991, Jarvis et al. 1996; Pette
1998; Olson and Williams 2000; Hood 2001). This conversion
of muscle ﬁber from type IIb to type IIa and type I is likely to
be mediated by a calcium signaling pathway that involves
calcineurin, calmodulin-dependent kinase, and the transcrip-
tional cofactor Peroxisome proliferator-activated receptor-
gamma coactivator 1a (PGC-1a) (Naya et al. 2000; Olson and
Williams 2000; Lin et al. 2002; Wu et al. 2002). However, the
targeted transcriptional factors directly responsible for
reprogramming the ﬁber-speciﬁc contractile and metabolic
genes remain to be identiﬁed.
Muscle ﬁber speciﬁcation appears to be associated with
obesity and diabetes. For instance, rodents that gain the most
weight on high-fat diets possess fewer type I ﬁbers (Abou et
al. 1992). In obese patients, skeletal muscle has been observed
to have reduced oxidative capacity, increased glycolytic
capacity, and a decreased percentage of type I ﬁbers (Hickey
et al. 1995; Tanner et al. 2002). Similar observations have
been made in type 2 diabetic patients (Lillioja et al. 1987;
Hickey et al. 1995). Recently, it has been shown that
increasing oxidative ﬁbers can lead to improved insulin
action and reduced adipocyte size (Luquet et al. 2003; Ryder
et al. 2003).
We have previously established that peroxisome prolifer-
ator-activated receptor (PPAR) d is a major transcriptional
regulator of fat burning in adipose tissue through activation
of enzymes associated with long-chain fatty-acid b-oxidation
(Wang et al. 2003). Although PPARd is the predominant PPAR
isoform present in skeletal muscle, its in vivo function has not
been determined. Our current study uncovers PPARd as the
ﬁrst transcription factor able to drive the formation of
functional type I muscle ﬁbers, whose activation entrains
complex pathways both enhancing physical performance and
creating a state of obesity resistance.
Results
Activation of PPARd Leads to Muscle Fiber Transformation
A role of PPARd in muscle ﬁber was suggested by its
enhanced expression—at levels 10-fold and 50-fold greater
than PPARa and c isoforms, respectively (unpublished data).
An examination of PPARd in different muscle ﬁbers reveals a
signiﬁcantly higher level in type I muscle (soleus) relative to
type II–rich muscle (extensor digitorum longus) or type I and
type II mixed muscle (gastrocnemius) (Figure 1A); this
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Open access, freely available online PLoS BIOLOGYexpression pattern closely resembles that of PGC-1a (Lin et
al. 2002). A similar pattern but with more pronounced
differences was found at the protein level (Figure 1B).
To directly assess the role of activation of PPARd in control
of muscle ﬁber plasticity and mitochondrial biogenesis, we
generated mice expressing a transgene in which the 78-
amino-acid VP16 activation domain was fused to the N-
terminus of full-length PPARd, under control of the 2.2-kb
human a-skeletal actin promoter. In agreement with the
previous characterization of this promoter (Brennan and
Hardeman 1993; Clapham et al. 2000), the VP16-PPARd
transgene was selectively expressed in skeletal muscle, with
10-fold less in the heart (Figure 1C). Among different types of
muscle ﬁbers, the levels of VP16-PPARd expression appeared
to be similar (unpublished data). As shown in Figure 1D for
gastrocnemius muscle, VP16-PPARd fusion protein was
produced at a level similar to that of endogenous PPARd in
wild-type littermates. Interestingly, the level of endogenous
muscle PPARd protein in the transgenic mice was much
higher than in the control littermates. The substantial
increase of endogenous PPARd may have been caused by a
switch to type I ﬁber (see below), which intrinsically expresses
higher levels of PPARd (Figure 1A and 1B).
Type I muscle can be readily distinguished from type II or
mixed muscle by its red color, because of its high concen-
tration of myoglobin, a protein typically expressed in
oxidative muscle ﬁbers. We found that muscles in the
transgenic mice appeared redder (Figure 2A), which is
particularly evident in the mixed type I/II ﬁbers of the
hindlimb (Figure 2B). Indeed, metachromatic staining re-
vealed a substantial muscle ﬁber transformation (Figure 2C).
In gastrocnemius muscle, we estimated that there was a 2-fold
increase of type I ﬁbers. A diagnostic component of oxidative
ﬁbers is their high myoglobin and mitochondrial content,
which is supported by the mRNA analysis shown in Figure 3A.
In addition to myoglobin, mitochondrial components for
electron transfer (cytochrome c and cytochrome c oxidase
[COX] II and IV) and fatty-acid b-oxidation enzymes were
elevated (Figure 3A; unpublished data). These effects appear
to be direct consequences of PPARd activation, as levels of
PGC-1a, a coactivator involved in muscle ﬁber switch and
mitochondrial biogenesis (Wu et al. 1999; Lehman et al. 2000;
Lin et al. 2002), remained unchanged. Southern blot analysis
detected a substantially higher copy number of the mito-
chondrial genome–encoded COXII DNA in the transgenic
mice (Figure 3B). Mitochondrial DNA was increased 2.3-fold
in gastrocnemius muscle of the transgenic mice (Figure 3C).
These results reveal a marked stimulation of mitochondrial
biogenesis and further support the idea that there is a muscle
ﬁber switch. This conclusion was also conﬁrmed by Western
blot analysis. As shown in Figure 3D, the characteristic type I
ﬁber proteins, such as myoglobin and cytochrome c and b,
were signiﬁcantly increased. More importantly, the special-
ized contraction protein troponin I (slow) of type I ﬁber was
robustly induced; this was accompanied by a marked
reduction of the specialized contraction protein troponin I
Figure 1. Expression of Endogenous
PPARd and VP16-PPARd Transgene in
Muscle
(A) Pooled RNA isolated from various
muscles of ﬁve wild-type male C57B6
mice was hybridized with indicated
probes. EDL, extensor digitorum longus;
Gastro, gastrocnemius.
(B) Pooled nuclear proteins (15 lg/lane)
isolated from muscles of ﬁve wild-type
male C57B6 were probed with anti-
PPARd antibody. RNA polymerase II
(Pol II) is shown as a loading control.
(C) Expression of the VP16-PPARd trans-
gene in various tissues. 10 lg of total
RNA from each tissue was hybridized
with a VP16 cDNA probe. Gastrocne-
mius muscle was used here.
(D) Nuclear proteins (15 lg/lane) isolated
from gastrocnemius muscle of the trans-
genic mice (TG) and the wild-type
littermates (WT) were probed with in-
dicated antibodies. The upper, nonspe-
ciﬁc band that cross-reacted with the
anti-PPARd antibody serves a loading
control.
DOI: 10.1371/journal.pbio.0020294.g001
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PPARd Regulates Muscle Fiber and Endurance(fast) of type II ﬁber, indicating a high degree of ﬁber
transformation. We next examined whether acute activation
of endogenous PPARd would induce similar target genes. In
agreement with the chronic effects in the transgenic mice, we
found that, after treatment of wild-type C57B6J mice with the
PPARd-speciﬁc agonist GW501516 for only 10 d, genes for
slow ﬁber contractile proteins, mitochondrial biogenesis, and
b-oxidation were all upregulated (Figure 3E). This indicates
that rapid, systematic, and coordinated changes of muscle
ﬁber properties toward type I can be achieved by activation
of the endogenous PPARd pathway.
Muscle Fiber Switch by PPARd Protects Against Obesity
A number of previous studies have shown that obese
individuals have fewer oxidative ﬁbers, implying that the
presence of oxidative ﬁbers alone may play a part in obesity
resistance. To test this possibility, we fed the transgenic mice
and their wild-type littermates with a high-fat diet for 97 d.
Although the initial body weights of the two groups were very
similar, the transgenic mice had gained less than 50% at day
47, and only one-third at day 97, of the weight gained by the
wild-type animals (Figure 4A). The transgenic mice displayed
signiﬁcantly higher oxygen consumption on the high-fat diet
than the control littermates (unpublished data). By the end of
this experiment, the control littermates became obese,
whereas the transgenic mice still maintained a normal body
weight and fat mass composition (Figure 4A). A histological
analysis of inguinal fat pad revealed a much smaller cell size
in the transgenic mice (Figure 4B), due to the increased
muscle oxidative capacity. While there was no signiﬁcant
difference in intramuscular glycogen content, the triglyceride
content was much less in the transgenic mice (Figure 4C and
4D), which may explain their improved glucose tolerance
(Figure 4E). We also placed wild-type C57BJ6 mice on the
high-fat diet and treated them with either vehicle or the
PPARd agonist GW501516 for 2 mo. GW501516 produced a
sustained induction of genes for type I muscle ﬁbers; this, at
least in part, resulted in an only 30% gain in body weight, a
dramatically reduced fat mass accumulation, and improved
glucose tolerance, compared to the vehicle-treated group
(Figure 5). Thus, muscle ﬁber conversion by stimulation with
the PPARd agonist or the activated transgene has a protective
role against obesity.
Activation of PPARd Enhances Physical Performance
Muscle oxidative capacity is a crucial factor for determin-
ing endurance and fatigue. Indeed, type I ﬁbers adaptively
generated through exercise training are considered to be
fatigue resistant. However, whether the type I ﬁbers
generated molecularly via PPARd expression can contribute
to enhanced performance in the absence of previous training
is unclear. In fact, the consequence of genetically induced
ﬁber switch on running capacity has to our knowledge never
been evaluated. We thus compared exercise performance
Figure 2. Increased Oxidative Type I Fibers
in the Transgenic Mice
(A and B) Muscles in transgenic mice
(TG) are redder than those in wild-type
mice (WT).
(C) Metachromatic staining of the type II
plantaris muscle. Type I ﬁbers are
stained dark blue.
DOI: 10.1371/journal.pbio.0020294.g002
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PPARd Regulates Muscle Fiber and Endurancebetween untrained, body-weight-matched transgenic and
wild-type littermates. Mice were run on oxygen-infused,
enclosed treadmills until exhaustion. Strikingly, the running
time and distance the transgenic mice were able to sustain
were increased by 67% and 92%, respectively (Figure 6A; also
see Videos S1 and S2). The transgenic mice ran about 1 h
longer than the controls, which translates to nearly a
kilometer further. No signiﬁcant differences in muscle mass
(unpublished data) and daily activity (total counts of activity
per hour: 1618 6 209 for transgenic versus 1987 6 301 for
wild-type, p . 0.35, n = 4) were observed between the
transgenic and control mice. Thus, the remarkable increase
in endurance is the physiologic manifestation of muscle ﬁber
transformation. This suggests that genetically directed
muscle ﬁber switch is physiologically and functionally
relevant. In addition, we looked at what effect the absence
of PPARd function has on exercise endurance. In the
treadmill test, the PPARd-null mice could sustain only 38%
of the running time and 34% of the distance of their age- and
weight-matched wild-type counterparts (Figure 6B). These
results further support a role for PPARd in enhancement of
physical performance.
Discussion
Our data reveal that a PPARd-mediated transcriptional
pathway can regulate muscle ﬁber speciﬁcation, enabling the
generation of a strain of mice with a ‘‘long-distance running’’
phenotype. We show that targeted expression of an activated
form of PPARd produces profound and coordinated in-
creases in oxidation enzymes, mitochondrial biogenesis, and
Figure 3. Activation of PPARd Induces
Genes Typical for Type I Fibers and
Promotes Mitochondrial Biogenesis
(A) Total RNA (10 lg/lane) prepared
from gastrocnemius muscle of transgenic
(TG) and wild-type (WT) littermates was
probed with indicated probes. The fold
increase of induction of each gene is
shown.
(B) Total genomic DNA (10 lg/lane)
prepared from gastrocnemius muscle
was digested with Nco1 and subjected
to Southern analysis with COXII (mito-
chondrial genome–encoded) and MCIP1
(nuclear genome–encoded) DNA probes.
(C) Equal amounts of gastrocnemius
muscle were collected from both trans-
genic mice and control littermates. Total
mitochondrial DNA was isolated and
separated on 1% agarose gel. The rela-
tive abundance of mitochondrial DNA in
transgenic and wild-type mice is pre-
sented.
(D) Western blot analysis of muscle ﬁber
markers and mitochondrial components.
Each lane was loaded with 80 lg of total
gastrocnemius muscle extracts.
(E) Wild-type C57B6 mice were treated
with vehicle or PPARd agonist
GW501516 for 10 d. Total RNA (10 lg/
lane) prepared from the gastrocnemius
m u s c l ew a sp r o b e dw i t hi n d i c a t e d
probes.
DOI: 10.1371/journal.pbio.0020294.g003
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the three hallmarks for muscle ﬁber type switching (Figure
6C). While induction of muscle oxidation enzymes by PPARd
has been seen both in vivo and in vitro (Muoio et al. 2002;
Dressel et al. 2003; Luquet et al. 2003; Tanaka et al. 2003;
Wang et al. 2003), its effects shown here on muscle ﬁber
switching are unexpected. These progressive changes in
oxidative capacity in conjunction with eventual changes in
type I muscle ﬁber lead to a dramatically improved exercise
proﬁle and protection against obesity. This does not solely
depend on achieving a directed muscle ﬁber type switch but
also requires all the associated changes in neural innervation,
motor neuron function, and peripheral metabolic adaptation
to enable a new integrated physiological response. Accord-
ingly, activation of muscle PPARd essentially recapitulates the
effects of exercise training even in the absence of training
itself. To our knowledge, this has not been directly described
for any other transcriptional factor.
The muscle phenotypes described here are remarkably
similar to those of transgenic mice expressing either
calcineurin, calmodulin-dependent kinase, or PGC-1a (Naya
et al. 2000; Lin et al. 2002; Wu et al. 2002), indicating that
PPARd could be one of the hypothetical downstream tran-
scription factors of these pathways. It is important to note
that, from our ligand and gain-of-function transgenic studies,
PPARd needs to be activated in order to direct the muscle
ﬁber switch. Indeed, in a recent report by Luquet et al. (2003),
simple overexpression of wild-type PPARd in muscle was
found not to be sufﬁcient to promote a ﬁber switch or obesity
resistance, although certain oxidation enzymes were in-
creased. This supports the model in Figure 6C that the
activating signal or ligand, but not the receptor, is limiting.
Thus, PPARd activation, rather than merely an increase of
PPARd levels, is an essential element for ﬁber switching and
its associated functional manifestations. How might endoge-
nous PPARd become activated naturally by exercise training?
First, it is possible that exercise generates or increases
endogenous ligands for PPARd as tissues are undergoing
substantial increases in fatty-acid internalization and burn-
ing. Fatty acids and their metabolites can activate PPARd.A
Figure 4. Resistance to High-Fat-Induced
Obesity in the Transgenic Mice
(A) Seven-week-old transgenic (TG) and
wild-type (WT) littermates (n = 5–6 for
each group) were fed with a high-fat diet
for 97 d. Left panel shows net body
weight gain, which was calculated for
individual mice and then averaged. Right
panel shows the body weights before
(Day 0) and after (Day 97) high-fat
feeding.
(B) Histology of inguinal fat pad in the
transgenic and wild-type littermates
under a high-fat diet for 2 mo.
(C and D) Intramuscular glycogen con-
tent (C) and triglyceride content (D) of
mice in (A) after high-fat feeding (n = 6).
(E) Glucose tolerance test. Mice in (A)
after high-fat feeding were fasted for 6 h
a n dt h e ni n j e c t e dw i t hg l u c o s ea ta
concentration of 1g/kg body weight.
Then blood glucose levels were measured
periodically over 2 h (n = 6).
DOI: 10.1371/journal.pbio.0020294.g004
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PPARd Regulates Muscle Fiber and Endurancesecond model is that exercise may induce expression of PGC-
1a (Goto et al. 2000) and thereby activate PPARd. This is
consistent with previous work in which we have shown that
PGC-1a physically associates with PPARd in muscle tissue and
can powerfully activate it even in the absence of ligands
(Wang et al. 2003). Alternatively, PPARd may be activated by a
distal upstream signaling component such as a kinase cascade.
Further dissecting the interactions between PPARd and its
regulatory components will be necessary to fully understand
the molecular basis of muscle ﬁber determination pertinent
to exercise training.
Skeletal muscle is a major site to regulate whole-body fatty-
acid and glucose metabolism. We show that mice with
increased oxidative ﬁbers are resistant to high-fat-induced
obesity and glucose intolerance. Moreover, ligand studies
provide compelling evidence that activation of endogenous
PPARd can produce similar effects. Might PPARd have any
beneﬁcial effects on glucose metabolism in the lean con-
dition? This has not been explored; however, insulin
resistance in the elderly is conﬁned mostly to skeletal muscle
and may be due to reduction of mitochondrial number and/
or function (Petersen et al. 2003). The ability of PPARd to
stimulate mitochondrial biogenesis and oxidative function
suggests that PPARd could be important for control of insulin
resistance during normal aging. Together, these data indicate
that PPARd and its ligands comprise a key molecular switch
to regulate muscle ﬁber speciﬁcation, obesity resistance,
insulin sensitivity, and, most surprisingly, physical endurance.
This work demonstrates that complex physiologic properties
such as fatigue, endurance, and running capacity can be
genetically manipulated.
Materials and Methods
Animals. The transactivation domain (78 amino acid residues,
corresponding to residues 413–490) of VP16 was fused in frame with
the N-terminus of mouse PPARd. The VP16-PPARd fusion cDNA was
placed downstream of the human a-skeletal actin promoter (Brennan
and Hardeman 1993), and upstream of the SV40 intron/poly(A)
sequence. The transgene was puriﬁed and injected into C57BL/6J 3
CBA F1 zygotes. Transgenic mice were backcrossed with C57BL/6J for
two generations. Wild-type littermates were used as controls
throughout the study. On normal chow diet, the transgenic mice
and control littermates used here had similar body weights. PPARd-
null mice were previously generated (Barak et al. 2002). Mice were fed
either a standard chow with 4% (w/w) fat content (Harlan Teklad,
Harlan, Indianapolis, Indiana, United States) or a high-fat diet
containing 35% (w/w) fat content (product F3282, Bioserv, French-
town, New Jersey, United States) as indicated. For ligand experiments,
we synthesized the GW501516 compound and mice were orally
gavaged daily (10 mg/kg or vehicle alone).
Figure 5. PPARd Agonists Counteract Obesity Induced by High-Fat Diet
(A) Eleven-week-old wild-type C57B6 mice were fed a high-fat diet in combination with vehicle or GW501516 for 57 d. Total RNA (10 lg/lane)
prepared from the gastrocnemius muscle was probed with indicated probes.
(B) Net body weight gain for mice in (A) after treatment was calculated for individual mice and averaged. Initial body weights were 28.54 6 1.04 g
for vehicle group (n = 5) and 28.86 6 0.80 g for GW501516 group (n = 5).
(C) Various tissue weights for mice in (A) after treatment. ifat, inguinal fat; rdfat, reproductive fat; retrofat, retroperitoneal fat.
(D) Glucose tolerance test. Mice in (A) after treatment were fasted for 6 h and then injected with glucose at a concentration of 1g/kg body weight.
Blood glucose levels were then measured periodically over 2 h.
DOI: 10.1371/journal.pbio.0020294.g005
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PPARd Regulates Muscle Fiber and EnduranceGene expression analysis and physiological studies. Mouse EST
clones were obtained from ATCC (Manassas, Virginia, United States),
veriﬁed by sequencing, and used as Northern probes. Antibodies
were obtained from Santa Cruz Biotechnology (Santa Cruz,
California, United States). Total muscle protein extracts (Lin et al.
2002) and nuclear proteins (Wang et al. 2003) were prepared as
described.
Prior to the exercise performance test, the mice were accustomed
to the treadmill (Columbus Instruments, Columbus, Ohio, United
States) with a 5-min run at 7 m/min once per day for 2 d. The exercise
test regimen was 10 m/min for the ﬁrst 60 min, followed by 1 m/min
increment increases at 15-min intervals. Exhaustion was deﬁned
when mice were unable to avoid repetitive electrical shocks.
Muscle ﬁber typing and mitochondrial DNA isolation. Muscle ﬁber
typing was essentially performed using metachromatic dye–ATPase
methods as described (Ogilvie and Feeback 1990). Muscle mitochon-
dria were isolated (Scholte et al. 1997). Mitochondrial DNA was
prepared and analyzed on 1% agarose gel.
Statistical analysis. Number of mice for each group used in
experiments is indicated in ﬁgure legends. Values are presented as
mean 6 SEM. A two-tailed Student’s t test was used to calculate p-
values.
Supporting Information
Video S1. Beginning of Running Test
This video shows the exercise performance of a representative of the
transgenic mice (right chamber) and a representative of wild-type
control littermates (left chamber) on the treadmill 15 min into the
exercise challenge.
Found at DOI: 10.1371/journal.pbio.0020294.sv001 (52.4 MB MOV).
Video S2. Running Test 90 Min Later
This video shows the exercise performance of a representative of the
transgenic mice (right chamber) and a representative of wild-type
control littermates (left chamber) on the treadmill 90 min into the
exercise challenge.
Found at DOI: 10.1371/journal.pbio.0020294.sv002 (41.7 MB MOV).
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